Speeds Recovery Reduces muscle soreness and promotes faster recovery
Contact your trial team immediately if you experience severe or persistent vomiting, signs of dehydration, severe abdominal pain radiating to the back, or upper right abdominal pain with fever or jaundice
It may come with bloating, slight nausea, or a feeling of fullness that lingers
Retatrutide is an investigational GLP-1, GIP, and glucagon triple receptor agonist not yet licensed in the UK or approved by the MHRA or EMA
Tirzepatide may be an excellent option for individuals who: Have a BMI of 30 or higher, or 27 or higher with health conditions such as hypertension or type 2 diabetes Struggle to lose weight despite consistent efforts with diet and exercise Are dedicated to making long-term lifestyle changes Have no history of severe allergic reactions to the medication Dont let obesity hold you back any longertake the first step towards a healthier, more vibrant life
What Action Does My Business Need To Take